Neil is a principal and consulting actuary with the London office of Milliman. He joined the firm in 2005 and was elected a principal in 2008. Prior to joining Milliman, Neil spent 15 years working in the UK operation of Winterthur. For five years, he sat on the main company board and had executive responsibility for strategy, legal, compliance, projects, marketing, product development, public relations, mergers and acquisitions, finance, and risk management. He has extensive knowledge of the UK retirement market.
At Milliman, assignments include enterprise risk management, mergers and acquisitions, product development, longevity, and corporate restructuring. Neil serves a wide range of clients globally, within and outside the financial services sector. Clients range from domestic to multi-national insurers and from diverse sectors including energy, mining and agriculture. Neil initiated, and leads, the global development of Milliman’s CRisALIS™ methodology for analyzing and quantifying enterprise risk. This cutting-edge approach utilizes insights from the complexity sciences and social sciences, such as anthropology and psychology.
Neil actively contributes to the promotion of actuaries in ERM and completed a prize winning research project on behalf of the UK Actuarial Profession in 2012 to develop practical tools for risk appetite and emerging risk. He also co-authored an award winning paper in 2013 with the UK Pension Protection Fund summarizing a project relating to reverse stress testing utilizing Milliman’s CRisALIS methods. In 2015 he co-authored the paper on systemic risk which won the ERM Research Excellence Award for best overall paper at the ERM Symposium.
In 2012 Neil was named as one of ten UK actuaries awarded the CERA designation as a Thought Leader and in 2015 was named amongst “the most influential” ERM practitioners in the UK by InsuranceERM Neil regularly speaks at professional and industry meetings, and business forums in the United States, Australasia, and Europe. Neil has had numerous articles published in journals and industry publications in the UK and the United States, and is regularly quoted in industry press.
